Literature DB >> 26519440

Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study.

Angela Winkler1, Christian Weimar1, Karl-Heinz Jöckel2, Raimund Erbel3, Nico Dragano4, Martina Broecker-Preuss5, Susanne Moebus2, Dagmar Führer-Sakel6, Martha Dlugaj1.   

Abstract

BACKGROUND: Although some studies reported on the association of serum thyroid-stimulating hormone (TSH) concentration and cognition, only one population-based study investigated the association of TSH concentration and mild cognitive impairment (MCI).
OBJECTIVE: To investigate the gender-specific association of low- and high-normal TSH concentrations with MCI in euthyroid participants.
METHODS: Analysis sample 1 included 2,563 euthyroid participants (aged 50-80 years) from the second examination of the population-based Heinz Nixdorf Recall study. Gender-specific TSH quintiles (Q1 low, Q2-Q4 middle, Q5 high TSH concentration) were determined and group comparisons of age- and education-adjusted mean scores were performed for all cognitive subtests. Analysis sample 2 included 378 participants with MCI and 931 cognitively normal participants. MCI was diagnosed according to previously published MCI criteria. Multivariate logistic regression models were performed using TSH quintiles (Q2-Q4 as reference) to assess the association of low- and high-normal TSH concentration with MCI. Models were performed unadjusted and adjusted for sociodemographic and cardiovascular risk factors.
RESULTS: Group comparisons showed significant differences only in the immediate recall of the verbal memory task in women. Only women showed a strong association of high-normal TSH concentration with MCI (unadjusted: odds ratio 2.09, 95% confidence interval 1.29-3.37, full adjusted: 1.86, 1.06-3.27). There was no association with low-normal TSH concentration in women and no association of either low- or high-normal TSH concentration with MCI in men.
CONCLUSIONS: These results suggest that women with high-normal TSH concentration might be at higher risk of cognitive decline. This needs to be confirmed in the longitudinal analysis.

Entities:  

Keywords:  Aging; gender; mild cognitive impairment; population-based studies; thyroid function; thyroid-stimulating hormone

Mesh:

Substances:

Year:  2016        PMID: 26519440     DOI: 10.3233/JAD-150561

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

Review 1.  Age-Related Resistance to Thyroid Hormone Action.

Authors:  Arshag D Mooradian
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

2.  Functional correlates of TSH, fT3 and fT4 in Alzheimer disease: a F-18 FDG PET/CT study.

Authors:  Agostino Chiaravalloti; Francesco Ursini; Alessandro Fiorentini; Gaetano Barbagallo; Alessandro Martorana; Giacomo Koch; Mario Tavolozza; Orazio Schillaci
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

3.  The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer's disease.

Authors:  Shohei Nomoto; Ryuta Kinno; Hirotaka Ochiai; Satomi Kubota; Yukiko Mori; Akinori Futamura; Azusa Sugimoto; Takeshi Kuroda; Satoshi Yano; Hidetomo Murakami; Takako Shirasawa; Takahiko Yoshimoto; Akira Minoura; Akatsuki Kokaze; Kenjiro Ono
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

Review 4.  Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis.

Authors:  Antonietta Messina; Carolina De Fusco; Vincenzo Monda; Maria Esposito; Fiorenzo Moscatelli; Anna Valenzano; Marco Carotenuto; Emanuela Viggiano; Sergio Chieffi; Vincenzo De Luca; Giuseppe Cibelli; Marcellino Monda; Giovanni Messina
Journal:  Front Neural Circuits       Date:  2016-08-25       Impact factor: 3.492

Review 5.  Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease.

Authors:  Marilu Jurado-Flores; Firas Warda; Arshag Mooradian
Journal:  J Endocr Soc       Date:  2022-01-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.